|  | Baseline | Two sessions | After pre-treatment | Start pain rehab treatment | Finish pain rehab treatment | 6 months after T3 |
---|---|---|---|---|---|---|---|
 | Abbr. | T0a |  | T1 | T2a | T3a | T4 |
Covariates | |||||||
Demographics patient | Â | x | Â | Â | Â | Â | Â |
Primary outcome effect evaluation | |||||||
Participation | USER-P | x | Â | x | Â | x | x |
Secondary outcomes effect evaluation | |||||||
Physical functioning/disability | PDI | x | Â | Â | x | x | x |
Pain intensity | VAS | x | Â | Â | x | x | x |
Main complaints | PSC | x | Â | Â | x | x | x |
Drop-out/adherence | Â | Â | Â | # | Â | # | Â |
Self-efficacy/perceived competence | GSE | x | Â | x | Â | x | x |
Pain-specific self-efficacy scale | CPSS_V2 | x | Â | x | Â | x | x |
Cost-effectiveness evaluation | |||||||
Cost questionnaire | Tic-P | x | Â | Â | x | Â | x |
Productivity losses | SF-HLQ | x | Â | Â | x | Â | x |
Quality of life/health status | SF-36 | x | Â | Â | x | x | x |
Potential active ingredients MI | |||||||
Stages of change | MPRCQ 2 | x | Â | x | Â | Â | Â |
MI integrity/fidelity | Â | Â | * | Â | Â | Â | Â |
Potential moderators | |||||||
Credibility and expectancy of the treatment | CEQ | x | Â | x | x | Â | Â |
Motivation | TMQ | x | Â | x | Â | Â | Â |
Depression | BDI | x | Â | Â | x | x | Â |
Acceptance | AAQ-II | x | Â | x | Â | x | Â |
Flexible goal-adjustment | FGA | x | Â | x | Â | x | Â |
Process evaluation | |||||||
Satisfaction with (pre-)treatment | Â | Â | Â | x + | Â | Â | Â |
Client-centeredness | CCCQ | Â | Â | x | Â | Â | Â |
Feasibility | Â | Â | Â | + | Â | Â | Â |